These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Effect of ketoconazole on the pharmacokinetics of imipramine and desipramine in healthy subjects. Spina E, Avenoso A, Campo GM, Scordo MG, Caputi AP, Perucca E. Br J Clin Pharmacol; 1997 Mar; 43(3):315-8. PubMed ID: 9088587 [Abstract] [Full Text] [Related]
11. Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction. Bergstrom RF, Peyton AL, Lemberger L. Clin Pharmacol Ther; 1992 Mar; 51(3):239-48. PubMed ID: 1544284 [Abstract] [Full Text] [Related]
12. An interaction of sertraline and desipramine. Barros J, Asnis G. Am J Psychiatry; 1993 Nov; 150(11):1751. PubMed ID: 8214190 [No Abstract] [Full Text] [Related]
13. Paroxetine shifts imipramine metabolism. Albers LJ, Reist C, Helmeste D, Vu R, Tang SW. Psychiatry Res; 1996 Jan 31; 59(3):189-96. PubMed ID: 8930024 [Abstract] [Full Text] [Related]
14. The Use of In Vitro Data and Physiologically-Based Pharmacokinetic Modeling to Predict Drug Metabolite Exposure: Desipramine Exposure in Cytochrome P4502D6 Extensive and Poor Metabolizers Following Administration of Imipramine. Nguyen HQ, Callegari E, Obach RS. Drug Metab Dispos; 2016 Oct 31; 44(10):1569-78. PubMed ID: 27440861 [Abstract] [Full Text] [Related]
15. Effect of venlafaxine on imipramine metabolism. Albers LJ, Reist C, Vu RL, Fujimoto K, Ozdemir V, Helmeste D, Poland R, Tang SW. Psychiatry Res; 2000 Nov 20; 96(3):235-43. PubMed ID: 11084219 [Abstract] [Full Text] [Related]
16. Investigation of the Differences in the Pharmacokinetics of CYP2D6 Substrates, Desipramine, and Dextromethorphan in Healthy African Subjects Carrying the Allelic Variants CYP2D6*17 and CYP2D6*29, When Compared with Normal Metabolizers. Marasanapalle VP, Masimirembwa C, Sivasubramanian R, Sayyed S, Weinzierl-Hinum A, Mehta D, Kapungu NN, Kanji C, Thelingwani R, Zack J. J Clin Pharmacol; 2024 May 20; 64(5):578-589. PubMed ID: 37803948 [Abstract] [Full Text] [Related]
17. Sertraline and imipramine for the treatment of dysthymia. de Jonghe F. Arch Gen Psychiatry; 1997 Oct 20; 54(10):973. PubMed ID: 9337782 [No Abstract] [Full Text] [Related]
18. Simultaneous determination of imipramine, desipramine and their 2- and 10-hydroxylated metabolites in human plasma and urine by high-performance liquid chromatography. Chen AG, Wing YK, Chiu H, Lee S, Chen CN, Chan K. J Chromatogr B Biomed Sci Appl; 1997 May 23; 693(1):153-8. PubMed ID: 9200529 [Abstract] [Full Text] [Related]
19. Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects. Spina E, Pollicino AM, Avenoso A, Campo GM, Perucca E, Caputi AP. Ther Drug Monit; 1993 Jun 23; 15(3):243-6. PubMed ID: 8333005 [Abstract] [Full Text] [Related]
20. Effects of imipramine and sertraline on protein kinase activity in rat frontal cortex. Tadokoro C, Kiuchi Y, Yamazaki Y, Oguchi K, Kamijima K. Eur J Pharmacol; 1998 Jan 19; 342(1):51-4. PubMed ID: 9544792 [Abstract] [Full Text] [Related] Page: [Next] [New Search]